New Health Insurance Initiative Expected to Save Reading Town Nearly $4 Million
Discover how Reading's new health insurance plan, expected to save $4 million, improves employee benefits and financial management for the town.
Understanding the Medicare Surtax: Implications for Florida's Economy
Explore the Medicare surtax's impact on Florida's economy and businesses, highlighting tax policy implications for families and high earners.
Expansion of Medicare Coverage for Immunotherapy Monitoring
Personalis Inc expands Medicare coverage for immunotherapy monitoring, enhancing cancer treatment precision and patient care with advanced diagnostics.
Humana Stock Surge Explained: Medicare Advantage and Earnings Performance
Explore Humana's 48% stock surge driven by Medicare Advantage developments and strong financial results. Analyze the impact on the insurance industry.
New ACA Regulations by CMS for 2027: Impact on Premiums and States
CMS introduces new ACA regulations for 2027, managing premiums, eligibility verification, and state oversight, affecting millions of enrollees.
Proposed Regulations on Fertility Benefits for Employers
Discover proposed regulations allowing employers to offer fertility benefits, exempt from ERISA, projected for 2027. Understand implications for health plans.
U.S. Departments Propose New Regulations for Fertility Benefits
Proposed regulations set guidelines for fertility benefits as limited excepted benefits, enhancing access to treatments and ensuring compliance with healthcare laws.
New CMS Rule Aims to Lower Health Insurance Costs and Combat Fraud
CMS's new federal rule aims to lower health care costs and enhance state oversight, impacting millions. Discover its implications for insurance affordability.
Oregon Health Insurance Premiums Set to Increase in 2025
Oregon health insurance premiums are rising in 2025, affecting 170,000 residents. Get insights on rate hikes from PacificSource and Providence Health Plan.
Trump's Investments in Eli Lilly: Implications for Healthcare and Ethics
Explore the implications of Trump's stock investments in Eli Lilly, focusing on ethical concerns and the impact on Medicare reimbursement policies.